Table 3.
Summary of clinical data of the STK11 exons 2–3 deletion carriers
| Patient | Gender | Age at diagnosis | Pigmentation | Hamartomatous polyps | Polyps localization | Cancer |
|---|---|---|---|---|---|---|
| Our study | F | 21 | Yes | Yes | Stomach, small intestine, colon | No |
| Chile [14] | F | 34 | Yes | Yes | Small intestine, colon | No |
| Italy II [15] | M | 4 | Yes | Yes | Stomach, small intestine, colon | No |
| Italy II [15] | M | 1 | No | Yes | Stomach, small intestine, colon | No |
| Italy I [12] | N/A | 5 | Yes | Yes | Intestine | N/A |
| Hungary [16] | F | 29 | Yes | Yes | Small intestine | N/A |
| Germany [7] | N/A | N/A | Yes | Yes | N/A | N/A |
| Korea [17] | N/A | N/A | N/A | Yes | N/A | N/A |
| UK [18] | M | 15 | N/A | N/A | N/A | No |
| Netherlands [19] | N/A | N/A | N/A | Yes | Intestine, nasal cavity | N/A |
| Australia [8] | F | 13 | Yes | Yes | N/A | N/A |
| Australia [8] | F | 35 | Yes | Yes | N/A | N/A |
N/A data not available, F female, M male